C. Bogedain

487 total citations
12 papers, 402 citations indexed

About

C. Bogedain is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, C. Bogedain has authored 12 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in C. Bogedain's work include Viral-associated cancers and disorders (6 papers), Virus-based gene therapy research (5 papers) and Enzyme Structure and Function (3 papers). C. Bogedain is often cited by papers focused on Viral-associated cancers and disorders (6 papers), Virus-based gene therapy research (5 papers) and Enzyme Structure and Function (3 papers). C. Bogedain collaborates with scholars based in Germany, Austria and United States. C. Bogedain's co-authors include Hans Wolf, Reinhard Hensel, Stefan Fabry, Wolfgang Jilg, Peter Zwickl, Alexander K. Haas, Susanne Modrow, György Stuber, Fritz Schwarzmann and Manfred Marschall and has published in prestigious journals such as Journal of Virology, FEBS Letters and Journal of Bacteriology.

In The Last Decade

C. Bogedain

12 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bogedain Germany 9 172 171 100 86 83 12 402
Nadia Bucurenci Romania 10 255 1.5× 86 0.5× 40 0.4× 112 1.3× 27 0.3× 21 373
Y. C. Cheng United States 11 449 2.6× 145 0.8× 28 0.3× 56 0.7× 113 1.4× 14 608
Victoria Doseeva United States 11 229 1.3× 88 0.5× 42 0.4× 25 0.3× 28 0.3× 21 418
Diana Chinchilla United States 7 206 1.2× 97 0.6× 167 1.7× 111 1.3× 40 0.5× 10 437
Nobuto Koyama Japan 11 334 1.9× 140 0.8× 166 1.7× 22 0.3× 46 0.6× 14 516
Sabine Vaganay France 8 278 1.6× 67 0.4× 18 0.2× 62 0.7× 25 0.3× 9 434
Petr Novák United States 7 225 1.3× 207 1.2× 21 0.2× 19 0.2× 25 0.3× 10 404
Batia Gorovitz Israel 7 176 1.0× 46 0.3× 27 0.3× 24 0.3× 52 0.6× 9 278
Alok K. Datta India 16 329 1.9× 107 0.6× 92 0.9× 40 0.5× 219 2.6× 29 571
M. Woisetschläger Austria 10 198 1.2× 57 0.3× 82 0.8× 16 0.2× 15 0.2× 14 325

Countries citing papers authored by C. Bogedain

Since Specialization
Citations

This map shows the geographic impact of C. Bogedain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bogedain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bogedain more than expected).

Fields of papers citing papers by C. Bogedain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bogedain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bogedain. The network helps show where C. Bogedain may publish in the future.

Co-authorship network of co-authors of C. Bogedain

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bogedain. A scholar is included among the top collaborators of C. Bogedain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bogedain. C. Bogedain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bogedain, C., Markus Hörer, Markus Braun‐Falco, et al.. (1998). Recombinant Adeno-Associated Virus for the Generation of Autologous, Gene-Modified Tumor Vaccines: Evidence for a High Transduction Efficiency into Primary Epithelial Cancer Cells. Human Gene Therapy. 9(7). 1049–1059. 26 indexed citations
2.
Hallek, Michael, Anne Girod, Markus Braun‐Falco, et al.. (1998). Recombinant adeno-associated virus vectors.. PubMed. 1(5). 561–73. 8 indexed citations
3.
Bogedain, C., et al.. (1997). The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells. International Journal of Immunopharmacology. 19(9-10). 473–479. 3 indexed citations
4.
Bogedain, C., Hans Wolf, Susanne Modrow, György Stuber, & Wolfgang Jilg. (1995). Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. Journal of Virology. 69(8). 4872–4879. 105 indexed citations
5.
Curiel, Tyler J., C. Bogedain, Wolfgang Jilg, et al.. (1994). Efficient Foreign Gene Expression in Epstein-Barr Virus-Transformed Human B-Cells. Virology. 198(2). 577–585. 12 indexed citations
7.
Hensel, Reinhard, et al.. (1994). Glyceraldehyde-3-Phosphate Dehydrogenases from Archaea: Objects for Studying Protein Thermoadaptation. Biocatalysis. 11(2). 151–164. 7 indexed citations
8.
Bogedain, C., et al.. (1994). Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines. Journal of Virology. 68(2). 1200–1203. 27 indexed citations
9.
Marschall, Manfred, et al.. (1993). The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells. Archives of Virology. 129(1-4). 23–33. 8 indexed citations
10.
Wolf, Hans, C. Bogedain, & Fritz Schwarzmann. (1993). Epstein-Barr Virus and Its Interaction with the Host. Intervirology. 35(1-4). 26–39. 31 indexed citations
12.
Zwickl, Peter, Stefan Fabry, C. Bogedain, Alexander K. Haas, & Reinhard Hensel. (1990). Glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic archaebacterium Pyrococcus woesei: characterization of the enzyme, cloning and sequencing of the gene, and expression in Escherichia coli. Journal of Bacteriology. 172(8). 4329–4338. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026